BUZZ-Citi ups PT for Australia's Sigma Healthcare after regulator approves merger with Chemist Warehouse

Reuters
2024-11-08

** Analysts at Citi raise PT for Sigma Healthcare to A$2.50 from A$1.40; maintain "Neutral" rating

** Wholesale pharmaceuticals distributor SIG received on Thursday Australian competition watchdog's approval for an A$8.8 bln ($5.87 bln) merger with private firm Chemist Warehouse

** Brokerage says the upgraded PT reflects Chemist Warehouse's potential in the combined Sigma Chemist Warehouse Group

** Brokerage expects the combined group to generate EBIT of ~A$800 mln in FY26, its first full year

** "The combined group should continue to perform well in the prevailing high cost of living environment" - Citi

** "The network continues to grow in Australia and there are prospects for further international expansion" - Citi

** Stock has more than doubled in value this year, as of last close

($1 = 1.4997 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10